The
global Artificial Intelligence In Cardiology Market size
is expected to reach USD 4.8 billion in 2030 and is projected to grow at a CAGR
of 24.6% from 2024 to 2030 The increase in the adoption of new
technologies by healthcare facilities for the diagnosis and treatment of
cardiac diseases, the growing burden of cardiovascular diseases worldwide, and
increasing competition among market players to launch new technologies for
cardiac imaging are some of the major factors supporting the market's growth.
According
to the WHO, cardiovascular diseases are a major cause of death worldwide. The
World Heart Federation states that cardiovascular deaths are expected to rise
in the coming years. i.e., from 18.9 million in 2020 to 32.3 million in 2050.
Some major causes of cardiac diseases are stress, sedentary lifestyles, and an
increase in the consumption of fast food, among others. A significant number of
people adopting a sedentary lifestyle is expected to increase the disease
burden further. This is expected to improve the demand for artificial
intelligence (AI) technology to accurately detect cardiac abnormalities and
thus boost the market in the post-pandemic period.
Aging
is one of the major causes of cardiovascular diseases. According to the National
Institute of Health, aging is one of the major reasons for diseases such as
coronary artery disease, stroke, heart attack, and other cardiovascular
diseases. According to the WHO, in 2020, over 1 billion people were aged 60
years and above, and by 2050, this number is expected to rise to 2.1 billion.
The surge in the geriatric population is expected to increase the burden of
these diseases and thus support the demand for advanced AI technology in the
coming years for treating heart diseases in a better way.
Artificial intelligence has improved and enhanced the
accuracy of diagnosing cardiovascular diseases. Machine learning algorithms are
increasingly being developed and are widely used in the diagnosis and treatment
of heart failure, valvular heart disease, and coronary artery disease, among
others. Improved diagnostic and prognostic capabilities using machine learning
algorithms are enhancing the clinical care of patients suffering from
cardiovascular diseases. Many studies have reported that artificial
intelligence detects abnormalities in the heart with more than 80% accuracy.
All the above-mentioned factors are likely to boost the demand for AI in
cardiology.
List of Key Players in Artificial Intelligence In
Cardiology Market
- IDOVEN
- CardiAI
- Ultromics
Limited
- Arterys Inc.
(Tempus)
- Cardiologs
(Koninklijke Philips N.V.)
- Ultrasight
- DiA Imaging
Analysis (Koninklijke Philips N.V.)
- Vista AI
- Viz ai
- RSIP Vision
- Cleerly,
Inc.
Request a
free sample copy or view report summary: Artificial Intelligence In Cardiology Market Report
Artificial Intelligence In Cardiology Market Report
Highlights
- Based on
component, software segment is expected to grow at the fastest CAGR during
the forecast period. AI-based software in cardiology is revolutionizing
the field by enhancing diagnostic accuracy, improving patient monitoring,
and enabling personalized treatments
- The cardiac
arrhythmias segment is expected to grow at the fastest CAGR over the
forecast period. Atrial Fibrillation (AF) is one of the most common
clinically significant cardiac arrhythmias associated with various
cardiovascular complications such as stroke and increased mortality.
- North
America dominated the artificial intelligence in cardiology market with a
revenue share of over 45.5% in 2023.
- The AI in
cardiology market in the Asia Pacific is expected to be driven by the
increasing prevalence of cardiovascular diseases in multiple countries,
fueling the demand for more efficient and accurate diagnostic &
treatment solutions
Artificial Intelligence In
Cardiology Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2024 |
USD 1.3 billion |
|
Revenue forecast in 2030 |
USD 4.8 billion |
|
Growth rate |
CAGR of 24.6% from 2024 to 2030 |
|
Actual data |
2018 - 2023 |
|
Forecast period |
2024 - 2030 |
Artificial Intelligence In Cardiology Market Segmentation
Grand
View Research has segmented the global artificial intelligence in cardiology
market report based on component, application, medical condition, and region:
Artificial Intelligence In Cardiology Component Outlook
(Revenue, USD Million, 2018 - 2030)
- Software
- Hardware
- Services
Artificial Intelligence In Cardiology Application Outlook
(Revenue, USD Million, 2018 - 2030)
- Diagnosis
- Prediction
- Drug
Discovery
- Others
Artificial Intelligence In Cardiology Medical Condition
Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiac
Arrhythmias
- Heart
Failure
- Ischemic
Heart Disease /CAD
- Others
Artificial Intelligence In Cardiology Regional Outlook
(Revenue, USD Million, 2018 - 2030)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin
America
- Brazil
- Mexico
- Argentina
- Middle East
& Africa
- South
Africa
- Saudi
Arabia
- UAE
- Kuwait
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
